Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-26T22:40:20.026Z Has data issue: false hasContentIssue false
  • English
  • Français

Systematic epidemiological and clinical comparisons across all 12 DSM-IV psychotic diagnoses in the Cavan–Monaghan First Episode Psychosis Study (CAMFEPS)

Published online by Cambridge University Press:  20 December 2019

Nnamdi Nkire ,
Paul J. Scully ,
David J. Browne ,
Patrizia A. Baldwin ,
Tara Kingston ,
Olabisi Owoeye ,
Anthony Kinsella ,
Eadbhard O'Callaghan ,
Vincent Russell  and
John L. Waddington Open the ORCID record for John L. Waddington [Opens in a new window]
Nnamdi Nkire
Affiliation:
Cavan-Monaghan Mental Health Service, St. Davnet's Hospital, Monaghan, and Cavan General Hospital, Cavan, Ireland Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland
Paul J. Scully
Affiliation:
Cavan-Monaghan Mental Health Service, St. Davnet's Hospital, Monaghan, and Cavan General Hospital, Cavan, Ireland Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland
David J. Browne
Affiliation:
Cavan-Monaghan Mental Health Service, St. Davnet's Hospital, Monaghan, and Cavan General Hospital, Cavan, Ireland Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland
Patrizia A. Baldwin
Affiliation:
Cavan-Monaghan Mental Health Service, St. Davnet's Hospital, Monaghan, and Cavan General Hospital, Cavan, Ireland Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland
Tara Kingston
Affiliation:
Cavan-Monaghan Mental Health Service, St. Davnet's Hospital, Monaghan, and Cavan General Hospital, Cavan, Ireland Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland
Olabisi Owoeye
Affiliation:
Cavan-Monaghan Mental Health Service, St. Davnet's Hospital, Monaghan, and Cavan General Hospital, Cavan, Ireland Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland
Anthony Kinsella
Affiliation:
Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland
Eadbhard O'Callaghan
Affiliation:
DETECT Early Psychosis Service, Blackrock, Co. Dublin, Ireland
Vincent Russell
Affiliation:
Cavan-Monaghan Mental Health Service, St. Davnet's Hospital, Monaghan, and Cavan General Hospital, Cavan, Ireland Department of Psychiatry, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland
John L. Waddington*
Affiliation:
Cavan-Monaghan Mental Health Service, St. Davnet's Hospital, Monaghan, and Cavan General Hospital, Cavan, Ireland Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland Jiangsu Key Laboratory of Translational Research & Therapy for Neuro-Psychiatric-Disorders and Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou, China
*
Author for correspondence: John L. Waddington, E-mail: jwadding@rcsi.ie
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Research on psychotic illness is loosening emphasis on diagnostic stringency in favour of including a more dimensionally based conceptualization of psychopathology and pathobiology. However, to clarify these notions requires investigation of the full scope of psychotic diagnoses.

Methods

The Cavan–Monaghan First Episode Psychosis Study ascertained cases of first episode psychosis across all 12 DSM-IV psychotic diagnoses via all routes to care: public, private or forensic; home-based, outpatient or inpatient. There was no arbitrary upper age cut-off and minimal impact of factors associated with variations in social milieu, ethnicity or urbanicity. Cases were evaluated epidemiologically and assessed for psychopathology, neuropsychology, neurology, antecedent factors, insight and quality of life.

Results

Among 432 cases, the annual incidence of any DSM-IV psychotic diagnosis was 34.1/100 000 of population and encompassed functional psychotic diagnoses, substance-induced psychopathology and psychopathology due to general medical conditions, through to psychotic illness that defied contemporary diagnostic algorithms. These 12 DSM-IV diagnostic categories, including psychotic disorder not otherwise specified, showed clinical profiles that were consistently more similar than distinct.

Conclusions

There are considerable similarities and overlaps across a broad range of diagnostic categories in the absence of robust discontinuities between them. Thus, psychotic illness may be of such continuity that it cannot be fully captured by operational diagnostic algorithms that, at least in part, assume discontinuities. This may reflect the impact of diverse factors each of which acts on one or more overlapping components of a common, dysfunctional neuronal network implicated in the pathobiology of psychotic illness.

Keywords

12 DSM-IV psychotic diagnosesclinical comparisonsdysfunctional neuronal networkepidemiologyfirst episode psychosis
Type
Original Article
Information
Psychological Medicine , Volume 51 , Issue 4 , March 2021 , pp. 607 - 616
Check for updates
Copyright
Copyright © Cambridge University Press 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

*

Deceased.

References

Ajnakina, O., Morgan, C., Gayer-Anderson, C., Oduola, S., Bourque, F., Bramley, S. … David, A. S. (2017). Only a small proportion of patients with first episode psychosis come via prodromal services: A retrospective survey of a large UK mental health service. BMC Psychiatry, 17, 308.10.1186/s12888-017-1468-yCrossRefGoogle Scholar
Aleman, A., Kahn, R. S., & Selten, J. P. (2003). Sex differences in the risk of schizophrenia: Evidence from meta-analysis. Archives of General Psychiatry, 60, 565–571.10.1001/archpsyc.60.6.565CrossRefGoogle ScholarPubMed
Amador, X. F., Strauss, D. H., Yale, S. A., Flaum, M. M., Endicott, J., & Gorman, J. M. (1993). Assessment of insight in psychosis. American Journal of Psychiatry, 150, 873–879.Google ScholarPubMed
Anderson, A. E., Marder, S., Reise, S. P., Savitz, A., Salvadore, G., Fu, D. J. … Bilder, R. M. (2018). Bifactor modeling of the Positive and Negative Syndrome Scale: Generalized psychosis spans schizoaffective, bipolar and schizophrenia diagnoses. Schizophrenia Bulletin, 44, 1204–1216.10.1093/schbul/sbx163CrossRefGoogle ScholarPubMed
Baldwin, P., Browne, D., Scully, P. J., Quinn, J. F., Morgan, M. J., Kinsella, A. … Waddington, J. L. (2005). Epidemiology of first-episode psychosis: Illustrating the challenges across diagnostic boundaries through the Cavan/Monaghan study at 8 years. Schizophrenia Bulletin, 31, 624–638.10.1093/schbul/sbi025CrossRefGoogle Scholar
Barbuti, M., Barbuti, M., Pacchiarotti, I., Vieta, E., Azorin, J. M., Angst, J. … BRIDGE-II-Mix Study Group (2017). Antidepressant-induced hypomania/mania in patients with major depression: Evidence from the BRIDGE-II-Mix study. Journal of Affective Disorders 219, 187–192.10.1016/j.jad.2017.05.035CrossRefGoogle ScholarPubMed
Barch, D. M., Bustillo, J., Gaebel, W., Gur, R., Heckers, S., Malaspina, D. … Carpenter, W. (2013). Logic and justification for dimensional assessment of symptoms and related phenomena in psychosis: Relevance to DSM-5. Schizophrenia Research, 150, 31–35.10.1016/j.schres.2013.04.027CrossRefGoogle ScholarPubMed
Bipolar Disorder and Schizophrenia Working Group of the Psychiatric Genomics Consortium (2018). Genomic dissection of bipolar disorder and schizophrenia, including 28 subphenotypes. Cell, 173, 1705–1715.10.1016/j.cell.2018.05.046CrossRefGoogle Scholar
Bora, E., Akgül, Ö, Ceylan, D., & Özerdem, A. (2018). Neurological soft signs in bipolar disorder in comparison to healthy controls and schizophrenia: A meta-analysis. European Neuropsychopharmacology, 28, 1185–1193.10.1016/j.euroneuro.2018.08.006CrossRefGoogle ScholarPubMed
Bora, E., & Pantelis, C. (2015). Meta-analysis of cognitive impairment in first-episode bipolar disorder: Comparison with first-episode schizophrenia and healthy controls. Schizophrenia Bulletin, 41, 1095–1104.10.1093/schbul/sbu198CrossRefGoogle ScholarPubMed
Brown, E. S., & Chandler, P. A. (2001). Mood and cognitive changes during systemic corticosteroid therapy. Primary Care Companion to the Journal of Clinical Psychiatry, 3, 17–21.10.4088/PCC.v03n0104CrossRefGoogle ScholarPubMed
Brainstorm Consortium (2018). Analysis of shared heritability in common disorders of the brain. Science, 360, eaap8757.10.1126/science.aap8757CrossRefGoogle Scholar
Brunette, M. F., Mueser, K. T., Babbin, S., Meyer-Kalos, P., Rosenheck, R., Correll, C. U. … Kane, J. M. (2018). Demographic and clinical correlates of substance use disorders in first episode psychosis. Schizophrenia Research, 194, 4–12.10.1016/j.schres.2017.06.039CrossRefGoogle ScholarPubMed
Buchanan, R. W., & Heinrichs, D. W. (1989). The Neurological Evaluation Scale (NES): A structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Research, 27, 335–350.10.1016/0165-1781(89)90148-0CrossRefGoogle Scholar
Cannon-Spoor, H. E., Potkin, S. G., & Wyatt, R. J. (1982). Measurement of premorbid adjustment in chronic schizophrenia. Schizophrenia Bulletin, 8, 470–484.10.1093/schbul/8.3.470CrossRefGoogle ScholarPubMed
Castillejos, M. C., Martin-Perez, C., & Moreno-Kustner, B. (2018). A systematic review and meta-analysis of the incidence of psychotic disorders: The distribution of rates and the influence of gender, urbanicity, immigration and socio-economic level. Psychological Medicine, 48, 2101–2115. doi: 10.1017/S0033291718000235CrossRefGoogle Scholar
Craddock, N., & Owen, M. J. (2010). The Kraepelinian dichotomy – going, going… but still not gone. British Journal of Psychiatry, 196, 92–95.10.1192/bjp.bp.109.073429CrossRefGoogle Scholar
Der-Avakian, A., & Markou, A. (2012). The neurobiology of anhedonia and other reward-related deficits. Trends in Neurosciences, 35, 68–77.10.1016/j.tins.2011.11.005CrossRefGoogle ScholarPubMed
First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. (2002). Structured clinical interview for the DSM-IV axis I disorders. New York: Biometrics Research.Google Scholar
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.10.1016/0022-3956(75)90026-6CrossRefGoogle Scholar
Fusar-Poli, P., Borgwardt, S., Bechdolf, A., Addington, J., Riecher-Rössler, A., Schultze-Lutter, F. … Yung, A. (2013). The psychosis high-risk state: A comprehensive state-of-the-art review. JAMA Psychiatry, 70, 107–120.10.1001/jamapsychiatry.2013.269CrossRefGoogle ScholarPubMed
Fusar-Poli, P., Cappucciati, M., Rutigliano, G., Heslin, M., Stahl, D., Brittenden, Z. … Carpenter, W. T. (2016). Diagnostic stability of ICD/DSM first episode psychosis diagnoses: Meta-analysis. Schizophrenia Bulletin, 42, 1395–1406.10.1093/schbul/sbw020CrossRefGoogle ScholarPubMed
García, S., Martínez-Cengotitabengoa, M., López-Zurbano, S., Zorrilla, I., López, P., Vieta, E., & González-Pinto, A. (2016). Adherence to antipsychotic medication in bipolar disorder and schizophrenic patients: A systematic review. Journal of Clinical Psychopharmacology, 36, 355–371.10.1097/JCP.0000000000000523CrossRefGoogle ScholarPubMed
Goodkind, M., Eickhoff, S. B., Oathes, D. J., Jiang, Y., Chang, A., Jones-Hagata, L. B. … Etkin, A. (2015). Identification of a common neurobiological substrate for mental illness. JAMA Psychiatry, 72, 305–315.10.1001/jamapsychiatry.2014.2206CrossRefGoogle ScholarPubMed
Guloksuz, S., & van Os, J. (2018). The slow death of the concept of schizophrenia and the painful birth of the psychosis spectrum. Psychological Medicine, 48, 229–244.10.1017/S0033291717001775CrossRefGoogle ScholarPubMed
Guy, W. (1976). ECDEU assessment manual for psychopharmacology: Publication ADM 76–338 (pp. 534–537). Washington, DC: US Department of Health, Education, and Welfare.Google Scholar
Heckers, S., Barch, D. M., Bustillo, J., Gaebel, W., Gur, R., Malaspina, D. … Carpenter, W. (2013). Structure of the psychotic disorders classification in DSM-5. Schizophrenia Research, 150, 11–14.10.1016/j.schres.2013.04.039CrossRefGoogle ScholarPubMed
Heinrichs, D. W., Hanlon, T. E., & Carpenter, W. T. (1984). The Quality of Life Scale: An instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin, 10, 388–398.10.1093/schbul/10.3.388CrossRefGoogle ScholarPubMed
Iacono, W. G., & Beiser, M. (1992). Where are the women in first-episode studies of schizophrenia? Schizophrenia Bulletin, 18, 471–480.10.1093/schbul/18.3.471CrossRefGoogle ScholarPubMed
Jääskeläinen, E., Juola, T., Korpela, H., Lehtiniemi, H., Nietola, M., Korkeila, J., & Miettunen, J. (2018). Epidemiology of psychotic depression – systematic review and meta-analysis. Psychological Medicine, 48, 905–918.10.1017/S0033291717002501CrossRefGoogle ScholarPubMed
Jongsma, H. E., Gayer-Anderson, C., Lasalvia, A., Quattrone, D., Mulè, A., Szöke, A. … European Network of National Schizophrenia Networks Studying Gene-Environment Interactions Work Package 2 (EU-GEI WP2) Group (2018). Treated incidence of psychotic disorders in the multinational EU-GEI study. JAMA Psychiatry 75, 36–46.10.1001/jamapsychiatry.2017.3554CrossRefGoogle ScholarPubMed
Joyce, E. M. (2018). Organic psychosis: The pathobiology and treatment of delusions. CNS Neuroscience and Therapeutics, 24, 598–603.10.1111/cns.12973CrossRefGoogle ScholarPubMed
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261–276.10.1093/schbul/13.2.261CrossRefGoogle Scholar
Khokhar, J. Y., Dwiel, L. L., Henricks, A. M., Doucette, W. T., & Green, A. I. (2018). The link between schizophrenia and substance use disorder: A unifying hypothesis. Schizophrenia Research, 194, 78–85.10.1016/j.schres.2017.04.016CrossRefGoogle ScholarPubMed
Kingston, T., Scully, P. J., Browne, D. J., Baldwin, P. A., Kinsella, A., Russell, V. … Waddington, J. L. (2013). Diagnostic trajectory, interplay and convergence/divergence across all 12 DSM-IV psychotic diagnoses: 6-year follow-up of the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS). Psychological Medicine, 43, 2523–2533.10.1017/S003329171300041XCrossRefGoogle Scholar
Kirkbride, J. B., Errazuriz, A., Croudace, T. J., Morgan, C., Jackson, D., Boydell, J. … Jones, P. B. (2012). Incidence of schizophrenia and other psychoses in England, 1950–2009: A systematic review and meta-analyses. PLoS ONE, 7, e31660.10.1371/journal.pone.0031660CrossRefGoogle ScholarPubMed
Kraguljac, N. V., White, D. M., Hadley, N., Hadley, J. A., Ver Hoef, L., Davis, E., & Lahti, A. C. (2016). Abberant hippocampal connectivity in unmedicated patients with schizophrenia and effects of antipsychotic medication: A longitudinal resting state functional MRI study. Schizophrenia Bulletin, 42, 1046–1055.10.1093/schbul/sbv228CrossRefGoogle Scholar
Lambert, C., Da Silva, S., Ceniti, A. K., Rizvi, S. J., Foussias, G., & Kennedy, S. H. (2018). Anhedonia in depression and schizophrenia: A transdiagnostic challenge. CNS Neuroscience and Therapeutics, 24, 615–623.10.1111/cns.12854CrossRefGoogle ScholarPubMed
Lewine, R., Burbach, D., & Meltzer, H. Y. (1984). Effect of diagnostic criteria on the ratio of male to female schizophrenic patients. American Journal of Psychiatry, 141, 84–87.Google ScholarPubMed
Longenecker, J., Genderson, J., Dickinson, D., Malley, J., Elvenag, B., Weinberger, D. R., & Gold, J. (2010). Where have all the women gone? Participant gender in epidemiological and non-epidemiological research in schizophrenia. Schizophrenia Research, 119, 240–245.10.1016/j.schres.2010.03.023CrossRefGoogle Scholar
Lyne, J., O'Donoghue, B., Owens, E., Renwick, L., Madigan, K., Kinsella, A. … O'Callaghan, E. (2012). Prevalence of item level negative symptoms in first episode psychosis diagnoses. Schizophrenia Research, 135, 128–133.10.1016/j.schres.2012.01.004CrossRefGoogle ScholarPubMed
Malla, A., & Payne, J. (2005). First-episode psychosis: Psychopathology, quality of life and functional outcome. Schizophrenia Bulletin, 31, 650–671.CrossRefGoogle ScholarPubMed
Nelson, H. E. (1982). National Reading Test (NART): Test manual. Windsor: NFER-Nelson.Google Scholar
Novick, D., Montgomery, W., Treuer, T., Aguado, J., Kraemer, S., & Haro, J. M. (2015). Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: Results from a 1-year European outpatient observational study. BMC Psychiatry, 15, 189.CrossRefGoogle ScholarPubMed
Omer, S., Finnegan, M., Pringle, D. G., Kinsella, A., Fearon, P., Russell, V. … Waddington, J. L. (2016). Socioeconomic status at birth and risk for first episode psychosis in rural Ireland: Eliminating the features of urbanicity in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS). Schizophrenia Research, 173, 84–89.CrossRefGoogle Scholar
Omer, S., Kirkbride, J. B., Pringle, D. G., Russell, V., O'Callaghan, E., & Waddington, J. L. (2014). Neighbourhood-level socio-environmental factors and incidence of first episode psychosis by place at onset in rural Ireland: The Cavan-Monaghan First Episode Psychosis Study (CAMFEPS). Schizophrenia Research, 152, 152–157.CrossRefGoogle Scholar
Owen, M. J. (2014). New approaches to psychiatric diagnostic classification. Neuron, 84, 564–571.10.1016/j.neuron.2014.10.028CrossRefGoogle ScholarPubMed
Owoeye, O., Kingston, T., Scully, P. J., Baldwin, P., Browne, D., Kinsella, A. … Waddington, J. L. (2013). Epidemiological and clinical characterization following a first psychotic episode in major depressive disorder: Comparisons with schizophrenia and bipolar I disorder in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS). Schizophrenia Bulletin, 39, 756–765.CrossRefGoogle Scholar
Parellada, M., Gomez-Vallejo, S., Burdeus, M., & Arango, C. (2017). Developmental differences between schizophrenia and bipolar disorder. Schizophrenia Bulletin, 43, 1176–1189.CrossRefGoogle ScholarPubMed
Peet, M., & Peters, S. (1995). Drug-induced mania. Drug Safety, 12, 146–153.CrossRefGoogle ScholarPubMed
Royall, D. R., Mahurin, R. K., & Gray, K. F. (1992). Bedside assessment of executive cognitive impairment: The executive interview. Journal of the American Geriatric Society, 40, 1221–1226.CrossRefGoogle ScholarPubMed
Sami, M., Khan, H., & Nilforooshan, R. (2015). Late onset mania as an organic syndrome: A review of case reports in the literature. Journal of Affective Disorders, 188, 226–231.CrossRefGoogle ScholarPubMed
Sarpal, D. K., Robinson, D. G., Lencz, T., Argyelan, M., Ikuta, T., Karlsgodt, K. … Malhotra, A. K. (2015). Antipsychotic activity and functional connectivity of the striatum in first-episode schizophrenia. JAMA Psychiatry, 72, 5–13.CrossRefGoogle Scholar
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014). Biological insights from 108 schizophrenia-associated genetic loci. Nature, 511, 421–427.CrossRefGoogle Scholar
Scully, P. J., Coakley, G., Kinsella, A., & Waddington, J. L. (1997). Psychopathology, executive (frontal) and general cognitive impairment in relation to duration of initially untreated versus subsequently treated psychosis in chronic schizophrenia. Psychological Medicine, 27, 1303–1310.CrossRefGoogle ScholarPubMed
Sheffield, J. M., Kandala, S., Tamminga, C. A., Pearlson, G. D., Keshavan, M. S., Sweeney, J. A. … Barch, D. M. (2017). Transdiagnostic associations between functional brain network integrity and cognition. JAMA Psychiatry, 74, 605–613.CrossRefGoogle ScholarPubMed
Simpson, G. M., & Angus, J. W. (1970). A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica Supplementum, 212, 11–19.CrossRefGoogle ScholarPubMed
Stafford, J., Howard, R., & Kirkbride, J. B. (2018). The incidence of very late-onset psychotic disorders: A systematic review and meta-analysis, 1960–2016. Psychological Medicine, 48, 1775–1786.CrossRefGoogle ScholarPubMed
Trotta, A., Murray, R. M., & MacCabe, J. H. (2015). Do premorbid and post-onset cognitive functioning differ between schizophrenia and bipolar disorder? A systematic review and meta-analysis. Psychological Medicine, 45, 381–394.10.1017/S0033291714001512CrossRefGoogle ScholarPubMed
Van der Werf, M., Hanssen, M., Kohler, S., Verkaaik, M., Verhey, F. R., RISE Investigators, van Winkel, R. … Allardyce, J. (2014). Systematic review and collaborative recalculation of 133693 incident cases of schizophrenia. Psychological Medicine 44, 9–16.CrossRefGoogle ScholarPubMed
van Os, J., & Kapur, S. (2009). Schizophrenia. Lancet, 374, 635–645.CrossRefGoogle ScholarPubMed
Waddington, J. L., & Buckley, P. F. (2013). Psychotic depression: An underappreciated window to explore the dimensionality and pathobiology of psychosis. Schizophrenia Bulletin, 39, 754–755.CrossRefGoogle Scholar
Waddington, J. L., Hennessy, R. J., O'Tuathaigh, C. M. P., Owoeye, O., & Russell, V. (2012). Schizophrenia and the lifetime trajectory of psychotic illness: Developmental neuroscience and pathobiology, redux. In Brown, A. S. & Patterson, P. H. (Eds), The origins of schizophrenia (pp. 3–21). New York: Columbia University Press.Google Scholar
Waddington, J. L., Kingston, T., Nkire, N., & Russell, V. (2019). Major depressive disorder with psychotic features: Confronting and resolving the dimensional challenge. In van Os, J., Tamminga, C. A., Ivleva, E. I. & Reininghaus, U. (Eds), Dimensions of psychosis: Comprehensive conceptualization and treatments. New York: Oxford University Press (in press).Google Scholar
Watson, P., Zhang, J. P., Rizvi, A., Tamaiev, J., Birnbaum, M. L., & Kane, J. (2018). A meta-analysis of factors associated with quality of life in first episode psychosis. Schizophrenia Research, 202, 26–36.CrossRefGoogle ScholarPubMed
Zhang, B., Lin, P., Shi, H., Öngür, D., Auerbach, R. P., Wang, X. … Wang, X. (2012). Mapping anhedonia-specific dysfunction in a transdiagnostic approach: An ALE meta-analysis. Brain Imaging and Behavior, 10, 920–939.10.1007/s11682-015-9457-6CrossRefGoogle Scholar